GleamWall
中文EN

PALX Palomino Laboratories Inc.

Semiconductors & Related Devices · OTC · SEC CIK 1938569 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-219.5%
TTM EPS YoY108.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-60.1%
ROA-55.5%
ROIC (approx.)-7,675.4%
Asset turnover—

Leverage & solvency

Liabilities / assets5.9%
Debt / equity0.00x
Current ratio18.90x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-21.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
R&D expense$1.80M$668,636$438,240—————
SG&A expense$2.62M$696,635$805,363$742,639$1.60M$337,445$17,828$4,005
Operating income-$4.42M-$1.37M-$1.24M-$742,639-$1.60M-$337,445-$17,828-$137,962
Interest expense—————$8,227$8,137—
Income tax-$1,000———————
Net income-$4.42M-$1.36M-$1.24M-$742,607-$1.82M$388,000-$985,000-$9,963
EBITDA-$4.40M-$1.35M-$1.24M—————
EPS (basic)-0.19-0.06-0.07—-0.540.15-0.44—
EPS (diluted)-0.19-0.06-0.07—-0.540.15-0.44—
Weighted avg. shares (diluted)22.82M21.82M18.51M—3.38M2.58M2.23M—
Balance sheet
Cash & equivalents$17.79M$19.44M$6.66M$8.12M$7.90M$1.72M$137,729$135,000
Current assets$17.90M$19.59M$6.83M$8.43M—$1,887$18,220$138,125
PP&E, net$1.38M$1.24M$315,573—————
Goodwill$26,000———————
Intangibles$21,000———————
Total assets$19.70M$21.04M$7.36M$8.43M$8.31M$1,887$18,220$138,125
Current liabilities$947,000$368,885$228,862$337,000$999,013$364,431$336,989$6,431
Total liabilities$1.17M$475,962$351,970$337,000$999,013$364,431$336,989$156,431
Shareholders' equity$18.53M$20.57M$7.01M$8.10M$7.32M-$447,000-$990,000-$17,000
Shares outstanding27.64M23.16M18.92M18.77M17.61M5.00M5.00M4.50M
Cash flow statement
Operating cash flow-$1.57M-$1.12M-$1.12M-$894,156-$309,969-$84,083$3,052-$5,700
Capital expenditure$128,348$941,316$318,336—————
Free cash flow-$1.70M-$2.06M-$1.43M—————
Investing cash flow-$58,348-$941,316-$318,336—————
Financing cash flow-$24,975$14.85M-$30,000$1.12M$6.48M$19,980$20$144,753
Depreciation & amortization$17,000$12,450$2,763—————
Stock-based compensation$2.35M$100,528—$18,406$1.26M$155,000——

Free plan shows the latest 8 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.